{
    "root": "8c5c7583-669a-7665-592f-de87f53bb4d4",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Aripiprazole",
    "value": "20250311",
    "ingredients": [
        {
            "name": "Aripiprazole",
            "code": "82VFR53I78",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31236"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "Magnesium Stearate",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "Tartaric Acid",
            "code": "W4888I119H",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "Croscarmellose Sodium",
            "code": "M28OL1HH48"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        }
    ],
    "indications": {
        "text": "aripiprazole tablets indicated treatment : schizophrenia irritability associated autistic disorder treatment tourette \u2019 disorder",
        "doid_entities": [
            {
                "text": "schizophrenia (DOID:5419)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_5419"
            },
            {
                "text": "autistic disorder (DOID:12849)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_12849"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "initial dose recommended dose maximum dose schizophrenia \u2013 adults ( 2.1 ) 10 15mg/day 10 15 mg/day 30 mg/day schizophrenia \u2013 adolescents ( 2.1 ) 2 mg/day 10 mg/day 30 mg/day irritability associated autistic disorder \u2013 pediatric patients ( 2.4 ) 2 mg/day 5 10 mg/day 15mg/day tourette \u2019 disorder \u2013 ( 2.5 ) patients < 50 kg 2 mg/day 5 mg/day 10mg/day patients \u2265 50 kg 2 mg/day 10 mg/day 20mg/day known cyp2d6 poor metabolizers : half usual dose ( 2.7 )",
        "doid_entities": [
            {
                "text": "schizophrenia (DOID:5419)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_5419"
            },
            {
                "text": "autistic disorder (DOID:12849)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_12849"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "supplied table 28 : aripiprazole tablet presentations tablet strength tablet color/shape tablet markings pack size ndc code 2 mg green , rectangular , slightly biconvex `` 2 `` `` `` bottle 30 60505-3075-3 bottle 1,000 60505-3075-8 5 mg blue , rectangular , slightly biconvex `` 5 `` `` `` bottle 30 60505-2673-3 bottle 1,000 60505-2673-8 10 mg pink , rectangular , slightly biconvex `` 10 `` `` `` bottle 30 60505-2674-3 bottle 1,000 60505-2674-8 15 mg yellow , round , slightly biconvex `` 15 `` `` apo `` bottle 30 60505-2675-3 bottle 1,000 60505-2675-8 20 mg white off-white , round , slightly biconvex `` 20 `` `` apo `` bottle 30 60505-2676-3 bottle 1,000 60505-2676-8 30 mg pink , round , slightly biconvex `` 30 `` `` apo `` bottle 30 60505-2677-3 bottle 1,000 60505-2677-3 storage store 25\u00b0c ( 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) [ usp controlled room temperature ] .",
    "adverseReactions": "aripiprazole tablets contraindicated patients history hypersensitivity reaction aripiprazole . ranged pruritus/urticaria anaphylaxis [ ( 6.2 ) ] .",
    "indications_original": "Aripiprazole tablets are indicated for the treatment of:\n                  \n                     Schizophrenia\n                     \u00a0Irritability Associated with Autistic Disorder \n                     Treatment of Tourette\u2019s Disorder",
    "contraindications_original": "Initial\u00a0Dose Recommended\u00a0Dose Maximum\u00a0Dose Schizophrenia\u00a0\u2013\u00a0adults\u00a0( 2.1 ) 10 to 15mg/day 10 to 15\u00a0mg/day 30\u00a0mg/day Schizophrenia\u00a0\u2013\u00a0adolescents\u00a0( 2.1 ) 2\u00a0mg/day 10\u00a0mg/day 30\u00a0mg/day Irritability associated with autistic\u00a0disorder \u2013 pediatric patients ( 2.4 ) 2 mg/day 5 to 10 mg/day 15mg/day Tourette\u2019s\u00a0disorder \u2013\u00a0( 2.5 ) Patients < 50 kg 2 mg/day 5 mg/day 10mg/day Patients\u00a0\u2265 50 kg 2 mg/day 10\u00a0mg/day 20mg/day Known CYP2D6 poor metabolizers: Half of the usual dose ( 2.7 )",
    "warningsAndPrecautions_original": "How Supplied\n                  \n                  \n                     Table 28: Aripiprazole Tablet Presentations\n                  \n                  \n                     \n                        \n                           \n                              Tablet Strength\n                           \n                           \n                              Tablet Color/Shape\n                           \n                           \n                              Tablet Markings\n                           \n                           \n                              Pack Size\n                           \n                           \n                              NDC Code\n                           \n                        \n                        \n                           \n                              2 mg\n                           \n                           green, rectangular, slightly biconvex\n                           \"2\" and \"A\"\n                           Bottle of 30\n                           60505-3075-3\n                        \n                        \n                           Bottle of 1,000\n                           60505-3075-8\n                        \n                        \n                           \n                              5 mg\n                           \n                           blue, rectangular, slightly biconvex\n                           \"5\" and \"A\"\n                           Bottle of 30\n                           60505-2673-3\n                        \n                        \n                           Bottle of 1,000\n                           60505-2673-8\n                        \n                        \n                           \n                              10 mg\n                           \n                           pink, rectangular, slightly biconvex\n                           \"10\" and \"A\"\n                           Bottle of 30\n                           60505-2674-3\n                        \n                        \n                           Bottle of 1,000\n                           60505-2674-8\n                        \n                        \n                           \n                              15 mg\n                           \n                           yellow, round, slightly biconvex\n                           \"15\" and \"APO\"\n                           Bottle of 30\n                           60505-2675-3\n                        \n                        \n                           Bottle of 1,000\n                           60505-2675-8\n                        \n                        \n                           \n                              20 mg\n                           \n                           white to off-white, round, slightly biconvex\n                           \"20\" and \"APO\"\n                           Bottle of 30\n                           60505-2676-3\n                        \n                        \n                           Bottle of 1,000\n                           60505-2676-8\n                        \n                        \n                           \n                              30 mg\n                           \n                           pink, round, slightly biconvex\n                           \"30\" and \"APO\"\n                           Bottle of 30\n                           60505-2677-3\n                        \n                        \n                           Bottle of 1,000\n                           60505-2677-3\n                        \n                     \n                  \n                  \n                     Storage\n                  \n                  Store at 25\u00b0C (77\u00b0F); excursions permitted from 15\u00b0C to 30\u00b0C (59\u00b0F to 86\u00b0F) [see USP Controlled Room Temperature].",
    "adverseReactions_original": "Aripiprazole tablets are contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. Reactions have ranged from pruritus/urticaria to anaphylaxis [see ADVERSE REACTIONS (6.2)].",
    "drug": [
        {
            "name": "Aripiprazole",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31236"
        }
    ]
}